| |
| |
|
| Insider
Information: |
Sharp Shalini |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
214,123 |
|
|
Indirect Shares
|
104,270 |
|
|
| Direct
Value |
$4,408,119 |
|
|
|
Indirect Value
|
$46,244 |
|
|
| Total
Shares |
318,393 |
|
|
| Total
Value |
$4,454,363 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 537.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agenus Inc |
AGEN |
Director |
2013-01-30 |
81,311 |
2015-09-28 |
104,270 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
EVP, Finance |
2020-10-14 |
97,812 |
|
0 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
35,000 |
2021-02-10 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2021-03-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGEN |
Agenus Inc |
CFOOfficer |
• – – |
2006-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,079 |
|
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
• – – |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,755 |
|
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2019-04-19 |
4 |
D |
$64.43 |
$15,979 |
D/D |
(248) |
66,078 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2020-04-19 |
4 |
D |
$58.57 |
$14,525 |
D/D |
(248) |
103,584 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2020-05-06 |
4 |
D |
$66.26 |
$16,432 |
D/D |
(248) |
103,336 |
0 |
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2012-08-29 |
4 |
AS |
$4.64 |
$1,336 |
D/D |
(288) |
76,602 |
0 |
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2012-10-31 |
4 |
AS |
$4.40 |
$1,267 |
D/D |
(288) |
80,974 |
0 |
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2013-01-30 |
4 |
AS |
$4.36 |
$1,256 |
D/D |
(288) |
81,311 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2018-06-01 |
4 |
D |
$73.73 |
$25,511 |
D/D |
(346) |
56,828 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2019-06-01 |
4 |
D |
$54.93 |
$19,006 |
D/D |
(346) |
67,246 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$24,144 |
D/D |
(348) |
101,208 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP, Finance |
• – – |
2020-10-14 |
4 |
S |
$87.99 |
$32,996 |
D/D |
(375) |
97,812 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2017-06-01 |
4 |
D |
$56.61 |
$21,285 |
D/D |
(376) |
55,470 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2018-05-21 |
4 |
D |
$64.79 |
$24,685 |
D/D |
(381) |
63,674 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2019-05-21 |
4 |
D |
$59.50 |
$22,670 |
D/D |
(381) |
67,592 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2018-03-01 |
4 |
D |
$48.43 |
$19,227 |
D/D |
(397) |
62,113 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Senior Vice President |
• – – |
2016-05-21 |
4 |
D |
$64.01 |
$26,500 |
D/D |
(414) |
41,387 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
• – – |
2017-05-21 |
4 |
D |
$57.47 |
$23,793 |
D/D |
(414) |
55,846 |
0 |
- |
|
| AGEN |
Agenus Inc |
CFO |
• – – |
2011-10-26 |
4 |
A |
$2.70 |
$1,688 |
D/D |
625 |
51,638 |
0 |
- |
|
| AGEN |
Agenus Inc |
CFO |
• – – |
2012-01-26 |
4 |
A |
$2.76 |
$1,725 |
D/D |
625 |
64,390 |
0 |
- |
|
| AGEN |
Agenus Inc |
CFO |
• – – |
2012-04-26 |
4 |
A |
$6.43 |
$4,019 |
D/D |
625 |
69,877 |
0 |
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2012-07-26 |
4 |
A |
$4.61 |
$2,881 |
D/D |
625 |
76,890 |
0 |
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2012-10-26 |
4 |
A |
$4.42 |
$2,763 |
D/D |
625 |
81,262 |
0 |
- |
|
| AGEN |
Agenus Inc |
Director |
– • – |
2013-01-28 |
4 |
A |
$4.35 |
$2,719 |
D/D |
625 |
81,599 |
0 |
- |
|
| AGEN |
Agenus Inc |
CFO |
• – – |
2011-12-23 |
4 |
S |
$2.20 |
$1,747 |
D/D |
(795) |
46,208 |
0 |
- |
|
128 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
